Location
United States, North America
Cheque size
$100K - $15M
Investment Stage
Pre Seed
Seed
Series A
Series B
Focus Areas
BioTech
Pharmaceuticals
About Investor
Michael Baran is Executive Director, Worldwide Business Development & Partner at Pfizer Ventures in New York City. He leads equity investments in biotech startups from pre-seed through Series B, with checks ranging from $100 K to $15 million (sweet spot $10 million), and his most recent commitment is to Capstan Therapeutics. He is based in New York. Prior to venture investing, he co-founded Nexomics Biosciences, managed R&D portfolio strategy for Pfizer, and serves as an adjunct assistant professor at Stony Brook University.
Previous investments
ImmunOs Therapeutics
11M |2024
73M |2022
15M |2019
Capstan Therapeutics
180M |2024
100M |2022
VitaDAO
4M |2023
500K |2022
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.